TY - JOUR AU - Herviou, L. AU - Cavalli, G. AU - Cartron, G. AU - Klein, B. AU - Moreaux, J. PY - 2016 DA - 2016// TI - EZH2 in normal hematopoiesis and hematological malignancies JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.6198 DO - 10.18632/oncotarget.6198 ID - Herviou2016 ER - TY - JOUR AU - Barlogie, B. AU - Mitchell, A. AU - van Rhee, F. AU - Epstein, J. AU - Morgan, G. J. AU - Crowley, J. PY - 2014 DA - 2014// TI - Curing myeloma at last: defining criteria and providing the evidence JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-07-552059 DO - 10.1182/blood-2014-07-552059 ID - Barlogie2014 ER - TY - JOUR AU - Lohr, J. G. AU - Stojanov, P. AU - Carter, S. L. AU - Cruz-Gordillo, P. AU - Lawrence, M. S. AU - Auclair, D. PY - 2014 DA - 2014// TI - Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy JO - Cancer Cell VL - 25 UR - https://doi.org/10.1016/j.ccr.2013.12.015 DO - 10.1016/j.ccr.2013.12.015 ID - Lohr2014 ER - TY - STD TI - Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5. https://doi.org/10.1038/ncomms3997. ID - ref4 ER - TY - JOUR AU - Delmore, J. E. AU - Issa, G. C. AU - Lemieux, M. E. AU - Rahl, P. B. AU - Shi, J. AU - Jacobs, H. M. PY - 2011 DA - 2011// TI - BET Bromodomain inhibition as a therapeutic strategy to target c-Myc JO - Cell VL - 146 UR - https://doi.org/10.1016/j.cell.2011.08.017 DO - 10.1016/j.cell.2011.08.017 ID - Delmore2011 ER - TY - JOUR AU - Moreaux, J. AU - Reme, T. AU - Leonard, W. AU - Veyrune, J. -. L. AU - Requirand, G. AU - Goldschmidt, H. PY - 2013 DA - 2013// TI - Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.392 DO - 10.1038/bjc.2013.392 ID - Moreaux2013 ER - TY - JOUR AU - Kalushkova, A. AU - Fryknäs, M. AU - Lemaire, M. AU - Fristedt, C. AU - Agarwal, P. AU - Eriksson, M. PY - 2010 DA - 2010// TI - Polycomb target genes are silenced in multiple myeloma JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0011483 DO - 10.1371/journal.pone.0011483 ID - Kalushkova2010 ER - TY - JOUR AU - Croonquist, P. A. AU - Van Ness, B. PY - 2005 DA - 2005// TI - The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype JO - Oncogene VL - 24 UR - https://doi.org/10.1038/sj.onc.1208771 DO - 10.1038/sj.onc.1208771 ID - Croonquist2005 ER - TY - JOUR AU - Zhao, F. AU - Chen, Y. AU - Li, R. AU - Liu, Y. AU - Wen, L. AU - Zhang, C. PY - 2010 DA - 2010// TI - Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro JO - Toxicology VL - 267 UR - https://doi.org/10.1016/j.tox.2009.10.023 DO - 10.1016/j.tox.2009.10.023 ID - Zhao2010 ER - TY - JOUR AU - Agarwal, P. AU - Alzrigat, M. AU - Párraga, A. A. AU - Enroth, S. AU - Singh, U. AU - Ungerstedt, J. PY - 2016 DA - 2016// TI - Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of polycomb gene targeting and highlights EZH2 as a potential therapeutic target JO - Oncotarget VL - 7 ID - Agarwal2016 ER - TY - JOUR AU - Hernando, H. AU - Gelato, K. A. AU - Lesche, R. AU - Beckmann, G. AU - Koehr, S. AU - Otto, S. PY - 2016 DA - 2016// TI - EZH2 inhibition blocks multiple myeloma cell growth through upregulation of epithelial tumor suppressor genes JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0486 DO - 10.1158/1535-7163.MCT-15-0486 ID - Hernando2016 ER - TY - STD TI - Alzrigat M, Párraga AA, Agarwal P, Zureigat H, Österborg A, Nahi H, et al. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions. OncoTarget. 2016. https://www.researchgate.net/profile/Mohammad_Alzrigat/publication/312021585_EZH2_inhibition_in_multiple_myeloma_downregulates_myeloma_associated_oncogenes_and_upregulates_microRNAs_with_potential_tumor_suppressor_functions/links/58694b7008ae8fce4917d807.pdf. Accessed 6 Apr 2017. UR - https://www.researchgate.net/profile/Mohammad_Alzrigat/publication/312021585_EZH2_inhibition_in_multiple_myeloma_downregulates_myeloma_associated_oncogenes_and_upregulates_microRNAs_with_potential_tumor_suppressor_functions/links/58694b7008ae8fce4917d807.pdf ID - ref12 ER - TY - JOUR AU - Pawlyn, C. AU - Bright, M. D. AU - Buros, A. F. AU - Stein, C. K. AU - Walters, Z. AU - Aronson, L. I. PY - 2017 DA - 2017// TI - Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control JO - Blood Cancer J VL - 7 UR - https://doi.org/10.1038/bcj.2017.27 DO - 10.1038/bcj.2017.27 ID - Pawlyn2017 ER - TY - JOUR AU - Kurmasheva, R. a. u. s. h. a. n. T. AU - Sammons, M. e. l. i. s. s. a. AU - Favours, E. d. w. a. r. d. AU - Wu, J. i. a. n. w. r. o. n. g. AU - Kurmashev, D. i. a. s. AU - Cosmopoulos, K. a. t. h. e. r. i. n. e. AU - Keilhack, H. e. i. k. e. AU - Klaus, C. h. r. i. s. t. i. n. e. R. AU - Houghton, P. e. t. e. r. J. AU - Smith, M. a. l. c. o. l. m. A. PY - 2016 DA - 2016// TI - Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program JO - Pediatric Blood & Cancer VL - 64 UR - https://doi.org/10.1002/pbc.26218 DO - 10.1002/pbc.26218 ID - Kurmasheva2016 ER - TY - JOUR AU - Moreaux, J. AU - Klein, B. AU - Bataille, R. AU - Descamps, G. AU - Maiga, S. AU - Hose, D. PY - 2011 DA - 2011// TI - A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines JO - Haematologica VL - 96 UR - https://doi.org/10.3324/haematol.2010.033456 DO - 10.3324/haematol.2010.033456 ID - Moreaux2011 ER - TY - JOUR AU - Hose, D. AU - Reme, T. AU - Hielscher, T. AU - Moreaux, J. AU - Messner, T. AU - Seckinger, A. PY - 2011 DA - 2011// TI - Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma JO - Haematologica VL - 96 UR - https://doi.org/10.3324/haematol.2010.030296 DO - 10.3324/haematol.2010.030296 ID - Hose2011 ER - TY - JOUR AU - Hose, D. AU - Rème, T. AU - Meissner, T. AU - Moreaux, J. AU - Seckinger, A. AU - Lewis, J. PY - 2009 DA - 2009// TI - Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-09-178350 DO - 10.1182/blood-2008-09-178350 ID - Hose2009 ER - TY - JOUR AU - Barlogie, B. PY - 2006 DA - 2006// TI - Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies JO - Blood VL - 107 UR - https://doi.org/10.1182/blood-2005-10-4084 DO - 10.1182/blood-2005-10-4084 ID - Barlogie2006 ER - TY - JOUR AU - Pineda-Roman, M. AU - Zangari, M. AU - van Rhee, F. AU - Anaissie, E. AU - Szymonifka, J. AU - Hoering, A. PY - 2008 DA - 2008// TI - VTD combination therapy with bortezomib–thalidomide–dexamethasone is highly effective in advanced and refractory multiple myeloma JO - Leukemia VL - 22 UR - https://doi.org/10.1038/leu.2008.99 DO - 10.1038/leu.2008.99 ID - Pineda-Roman2008 ER - TY - JOUR AU - Mulligan, G. AU - Mitsiades, C. AU - Bryant, B. AU - Zhan, F. AU - Chng, W. J. AU - Roels, S. PY - 2007 DA - 2007// TI - Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-09-044974 DO - 10.1182/blood-2006-09-044974 ID - Mulligan2007 ER - TY - JOUR AU - Dobin, A. AU - Davis, C. A. AU - Schlesinger, F. AU - Drenkow, J. AU - Zaleski, C. AU - Jha, S. PY - 2013 DA - 2013// TI - STAR: ultrafast universal RNA-seq aligner JO - Bioinformatics VL - 29 UR - https://doi.org/10.1093/bioinformatics/bts635 DO - 10.1093/bioinformatics/bts635 ID - Dobin2013 ER - TY - JOUR AU - Gentleman, R. C. AU - Carey, V. J. AU - Bates, D. M. AU - Bolstad, B. AU - Dettling, M. AU - Dudoit, S. PY - 2004 DA - 2004// TI - Bioconductor: open software development for computational biology and bioinformatics JO - Genome Biol VL - 5 UR - https://doi.org/10.1186/gb-2004-5-10-r80 DO - 10.1186/gb-2004-5-10-r80 ID - Gentleman2004 ER - TY - STD TI - Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15. https://doi.org/10.1186/s13059-014-0550-8. ID - ref23 ER - TY - JOUR AU - Liberzon, A. AU - Subramanian, A. AU - Pinchback, R. AU - Thorvaldsdottir, H. AU - Tamayo, P. AU - Mesirov, J. P. PY - 2011 DA - 2011// TI - Molecular signatures database (MSigDB) 3.0 JO - Bioinformatics VL - 27 UR - https://doi.org/10.1093/bioinformatics/btr260 DO - 10.1093/bioinformatics/btr260 ID - Liberzon2011 ER - TY - JOUR AU - Subramanian, A. AU - Tamayo, P. AU - Mootha, V. K. AU - Mukherjee, S. AU - Ebert, B. L. AU - Gillette, M. A. PY - 2005 DA - 2005// TI - Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles JO - Proc Natl Acad Sci VL - 102 UR - https://doi.org/10.1073/pnas.0506580102 DO - 10.1073/pnas.0506580102 ID - Subramanian2005 ER - TY - JOUR AU - Kassambara, A. AU - Rème, T. AU - Jourdan, M. AU - Fest, T. AU - Hose, D. AU - Tarte, K. PY - 2015 DA - 2015// TI - GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells JO - PLoS Comput Biol VL - 11 UR - https://doi.org/10.1371/journal.pcbi.1004077 DO - 10.1371/journal.pcbi.1004077 ID - Kassambara2015 ER - TY - JOUR AU - Küffner, R. AU - Zach, N. AU - Norel, R. AU - Hawe, J. AU - Schoenfeld, D. AU - Wang, L. PY - 2014 DA - 2014// TI - Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression JO - Nat Biotechnol VL - 33 UR - https://doi.org/10.1038/nbt.3051 DO - 10.1038/nbt.3051 ID - Küffner2014 ER - TY - JOUR AU - Moreaux, J. AU - Reme, T. AU - Leonard, W. AU - Veyrune, J. -. L. AU - Requirand, G. AU - Goldschmidt, H. PY - 2012 DA - 2012// TI - Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitors JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-12-0721 DO - 10.1158/1535-7163.MCT-12-0721 ID - Moreaux2012 ER - TY - JOUR AU - Aryee, M. J. AU - Jaffe, A. E. AU - Corrada-Bravo, H. AU - Ladd-Acosta, C. AU - Feinberg, A. P. AU - Hansen, K. D. PY - 2014 DA - 2014// TI - Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays JO - Bioinformatics VL - 30 UR - https://doi.org/10.1093/bioinformatics/btu049 DO - 10.1093/bioinformatics/btu049 ID - Aryee2014 ER - TY - JOUR AU - Lawrence, M. i. c. h. a. e. l. AU - Huber, W. o. l. f. g. a. n. g. AU - Pagès, H. e. r. v. é. AU - Aboyoun, P. a. t. r. i. c. k. AU - Carlson, M. a. r. c. AU - Gentleman, R. o. b. e. r. t. AU - Morgan, M. a. r. t. i. n. T. AU - Carey, V. i. n. c. e. n. t. J. PY - 2013 DA - 2013// TI - Software for Computing and Annotating Genomic Ranges JO - PLoS Computational Biology VL - 9 UR - https://doi.org/10.1371/journal.pcbi.1003118 DO - 10.1371/journal.pcbi.1003118 ID - Lawrence2013 ER - TY - JOUR AU - Hothorn, T. AU - Lausen, B. PY - 2003 DA - 2003// TI - On the exact distribution of maximally selected rank statistics JO - Comput Stat Data Anal VL - 43 UR - https://doi.org/10.1016/S0167-9473(02)00225-6 DO - 10.1016/S0167-9473(02)00225-6 ID - Hothorn2003 ER - TY - JOUR AU - Cummin, T. E. AU - Araf, S. AU - Du, M. AU - Barrans, S. AU - Bentley, M. A. AU - Clipson, A. PY - 2017 DA - 2017// TI - Prognostic significance and correlation to gene expression profile of EZH2 mutations in diffuse large b-cell lymphoma (DLBL) in 2 large prospective studies JO - Hematol Oncol VL - 35 UR - https://doi.org/10.1002/hon.2438_13 DO - 10.1002/hon.2438_13 ID - Cummin2017 ER - TY - JOUR AU - Guirguis, A. A. AU - Ebert, B. L. PY - 2015 DA - 2015// TI - Lenalidomide: deciphering mechanisms of action in myeloma, myelodysplastic syndrome and beyond JO - Curr Opin Cell Biol VL - 37 UR - https://doi.org/10.1016/j.ceb.2015.10.004 DO - 10.1016/j.ceb.2015.10.004 ID - Guirguis2015 ER - TY - JOUR AU - Bjorklund, C. C. AU - Lu, L. AU - Kang, J. AU - Hagner, P. R. AU - Havens, C. G. AU - Amatangelo, M. PY - 2015 DA - 2015// TI - Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4 JO - Blood Cancer J VL - 5 UR - https://doi.org/10.1038/bcj.2015.66 DO - 10.1038/bcj.2015.66 ID - Bjorklund2015 ER - TY - JOUR AU - Ezponda, T. AU - Dupéré-Richer, D. AU - Will, C. M. AU - Small, E. C. AU - Varghese, N. AU - Patel, T. PY - 2017 DA - 2017// TI - UTX/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition JO - Cell Rep VL - 21 UR - https://doi.org/10.1016/j.celrep.2017.09.078 DO - 10.1016/j.celrep.2017.09.078 ID - Ezponda2017 ER - TY - JOUR AU - Garapaty-Rao, S. AU - Nasveschuk, C. AU - Gagnon, A. AU - Chan, E. Y. AU - Sandy, P. AU - Busby, J. PY - 2013 DA - 2013// TI - Identification of EZH2 and EZH1 small molecule inhibitors with selective impact on diffuse large B cell lymphoma cell growth JO - Chem Biol VL - 20 UR - https://doi.org/10.1016/j.chembiol.2013.09.013 DO - 10.1016/j.chembiol.2013.09.013 ID - Garapaty-Rao2013 ER - TY - JOUR AU - Viré, E. AU - Brenner, C. AU - Deplus, R. AU - Blanchon, L. AU - Fraga, M. AU - Didelot, C. PY - 2005 DA - 2005// TI - The Polycomb group protein EZH2 directly controls DNA methylation JO - Nature VL - 439 UR - https://doi.org/10.1038/nature04431 DO - 10.1038/nature04431 ID - Viré2005 ER - TY - JOUR AU - Toyota, M. AU - Ho, C. AU - Ohe-Toyota, M. AU - Baylin, S. B. AU - Issa, J. -. P. J. PY - 1999 DA - 1999// TI - Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors JO - Cancer Res VL - 59 ID - Toyota1999 ER - TY - JOUR AU - Cha, Y. AU - Kim, K. -. J. AU - Han, S. -. W. AU - Rhee, Y. Y. AU - Bae, J. M. AU - Wen, X. PY - 2016 DA - 2016// TI - Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer JO - Br J Cancer VL - 115 UR - https://doi.org/10.1038/bjc.2016.176 DO - 10.1038/bjc.2016.176 ID - Cha2016 ER - TY - STD TI - Ohkubo T. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells. Int J Oncol. 2012. https://doi.org/10.3892/ijo.2012.1422. ID - ref40 ER - TY - JOUR AU - Cohen, Y. AU - Merhavi-Shoham, E. AU - Avraham, R. B. AU - Frenkel, S. AU - Pe’er, J. AU - Goldenberg-Cohen, N. PY - 2008 DA - 2008// TI - Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma JO - Exp Eye Res VL - 86 UR - https://doi.org/10.1016/j.exer.2007.10.010 DO - 10.1016/j.exer.2007.10.010 ID - Cohen2008 ER - TY - JOUR AU - Bailey, C. M. AU - Abbott, D. E. AU - Margaryan, N. V. AU - Khalkhali-Ellis, Z. AU - Hendrix, M. J. C. PY - 2008 DA - 2008// TI - Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner JO - Mol Cell Biol VL - 28 UR - https://doi.org/10.1128/MCB.01866-07 DO - 10.1128/MCB.01866-07 ID - Bailey2008 ER - TY - JOUR AU - Zengin, T. AU - Ekinci, B. AU - Kucukkose, C. AU - Yalcin-Ozuysal, O. PY - 2015 DA - 2015// TI - IRF6 is involved in the regulation of cell proliferation and transformation in MCF10A cells downstream of notch signaling JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0132757 DO - 10.1371/journal.pone.0132757 ID - Zengin2015 ER - TY - JOUR AU - Mostovich, L. A. AU - Prudnikova, T. Y. AU - Kondratov, A. G. AU - Loginova, D. AU - Vavilov, P. V. AU - Rykova, V. I. PY - 2011 DA - 2011// TI - Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors JO - Cell Adhes Migr VL - 5 UR - https://doi.org/10.4161/cam.5.5.17949 DO - 10.4161/cam.5.5.17949 ID - Mostovich2011 ER - TY - JOUR AU - Senchenko, V. N. AU - Kisseljova, N. P. AU - Ivanova, T. A. AU - Dmitriev, A. A. AU - Krasnov, G. S. AU - Kudryavtseva, A. V. PY - 2013 DA - 2013// TI - Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer JO - Epigenetics VL - 8 UR - https://doi.org/10.4161/epi.24233 DO - 10.4161/epi.24233 ID - Senchenko2013 ER - TY - JOUR AU - Nawaz, I. AU - Hu, L. -. F. AU - Du, Z. -. M. AU - Moumad, K. AU - Ignatyev, I. AU - Pavlova, T. V. PY - 2015 DA - 2015// TI - Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.5154 DO - 10.18632/oncotarget.5154 ID - Nawaz2015 ER - TY - JOUR AU - Mumby, M. PY - 2007 DA - 2007// TI - PP2A: unveiling a reluctant tumor suppressor JO - Cell VL - 130 UR - https://doi.org/10.1016/j.cell.2007.06.034 DO - 10.1016/j.cell.2007.06.034 ID - Mumby2007 ER - TY - JOUR AU - Bluemn, E. G. AU - Spencer, E. S. AU - Mecham, B. AU - Gordon, R. R. AU - Coleman, I. AU - Lewinshtein, D. PY - 2013 DA - 2013// TI - PPP2R2C loss promotes castration-resistance and is associated with increased prostate Cancer-specific mortality JO - Mol Cancer Res VL - 11 UR - https://doi.org/10.1158/1541-7786.MCR-12-0710 DO - 10.1158/1541-7786.MCR-12-0710 ID - Bluemn2013 ER - TY - JOUR AU - Bi, D. AU - Ning, H. AU - Liu, S. AU - Que, X. AU - Ding, K. PY - 2016 DA - 2016// TI - miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C JO - Biomed Pharmacother VL - 81 UR - https://doi.org/10.1016/j.biopha.2016.03.043 DO - 10.1016/j.biopha.2016.03.043 ID - Bi2016 ER - TY - JOUR AU - Wu, A. -. H. AU - Huang, Y. AU - Zhang, L. -. Z. AU - Tian, G. AU - Liao, Q. -. Z. AU - Chen, S. -. L. PY - 2016 DA - 2016// TI - MiR-572 prompted cell proliferation of human ovarian cancer cells by suppressing PPP2R2C expression JO - Biomed Pharmacother VL - 77 UR - https://doi.org/10.1016/j.biopha.2015.12.005 DO - 10.1016/j.biopha.2015.12.005 ID - Wu2016 ER - TY - JOUR AU - Fan, Y. AU - Chen, L. AU - Wang, J. AU - Yao, Q. AU - Wan, J. PY - 2013 DA - 2013// TI - Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway JO - FEBS Lett VL - 587 UR - https://doi.org/10.1016/j.febslet.2013.09.029 DO - 10.1016/j.febslet.2013.09.029 ID - Fan2013 ER - TY - JOUR AU - Sugita, Y. AU - Ohwada, C. AU - Kawaguchi, T. AU - Muto, T. AU - Tsukamoto, S. AU - Takeda, Y. PY - 2016 DA - 2016// TI - Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: a multicenter prospective analysis JO - Clin Chim Acta VL - 463 UR - https://doi.org/10.1016/j.cca.2016.10.008 DO - 10.1016/j.cca.2016.10.008 ID - Sugita2016 ER - TY - STD TI - Krzeminski P, Corchete LA, García JL, López-Corral L, Fermiñán E, García EM, et al. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse. Oncotarget. 2016. https://doi.org/10.18632/oncotarget.13025. ID - ref53 ER - TY - JOUR AU - Guijarro, M. V. AU - Leal, J. F. M. AU - Blanco-Aparicio, C. AU - Alonso, S. AU - Fominaya, J. AU - Lleonart, M. PY - 2007 DA - 2007// TI - MAP17 enhances the malignant behavior of tumor cells through ROS increase JO - Carcinogenesis VL - 28 UR - https://doi.org/10.1093/carcin/bgm124 DO - 10.1093/carcin/bgm124 ID - Guijarro2007 ER - TY - JOUR AU - Wu, C. PY - 2005 DA - 2005// TI - Migfilin and its binding partners: from cell biology to human diseases JO - J Cell Sci VL - 118 UR - https://doi.org/10.1242/jcs.01639 DO - 10.1242/jcs.01639 ID - Wu2005 ER - TY - JOUR AU - Fan, J. AU - Ou, Y. AU - Wu, C. AU - Yu, C. AU - Song, Y. AU - Zhan, Q. PY - 2012 DA - 2012// TI - Migfilin sensitizes cisplatin-induced apoptosis in human glioma cells in vitro JO - Acta Pharmacol Sin VL - 33 UR - https://doi.org/10.1038/aps.2012.123 DO - 10.1038/aps.2012.123 ID - Fan2012 ER - TY - JOUR AU - Gkretsi, V. AU - Papanikolaou, V. AU - Zacharia, L. C. AU - Athanassiou, E. AU - Wu, C. AU - Tsezou, A. PY - 2013 DA - 2013// TI - Mitogen-inducible Gene-2 (MIG2) and migfilin expression is reduced in samples of human breast cancer JO - Anticancer Res VL - 33 ID - Gkretsi2013 ER - TY - JOUR AU - Ma, H. AU - Wang, L. AU - Zhang, T. AU - Shen, H. AU - Du, J. PY - 2016 DA - 2016// TI - Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients JO - Tumor Biol VL - 37 UR - https://doi.org/10.1007/s13277-015-3886-0 DO - 10.1007/s13277-015-3886-0 ID - Ma2016 ER - TY - JOUR AU - Shen, H. o. n. g. c. h. a. n. g. AU - Wang, L. i. g. u. a. n. g. AU - Zhang, J. i. a. n. g. a. n. g. AU - Dong, W. e. i. AU - Zhang, T. i. e. h. o. n. g. AU - Ni, Y. a. n. g. AU - Cao, H. o. n. g. x. i. n. AU - Wang, K. a. i. AU - Li, Y. u. n. AU - Wang, Y. i. b. i. n. g. AU - Du, J. i. a. j. u. n. PY - 2016 DA - 2016// TI - ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response JO - Oncology Reports VL - 37 UR - https://doi.org/10.3892/or.2016.5337 DO - 10.3892/or.2016.5337 ID - Shen2016 ER - TY - JOUR AU - Kumar, A. AU - Bhanja, A. AU - Bhattacharyya, J. AU - Jaganathan, B. G. PY - 2016 DA - 2016// TI - Multiple roles of CD90 in cancer JO - Tumor Biol VL - 37 UR - https://doi.org/10.1007/s13277-016-5112-0 DO - 10.1007/s13277-016-5112-0 ID - Kumar2016 ER - TY - JOUR AU - Cavo, M. AU - Rajkumar, S. V. AU - Palumbo, A. AU - Moreau, P. AU - Orlowski, R. AU - Blade, J. PY - 2011 DA - 2011// TI - International myeloma working group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2011-02-297325 DO - 10.1182/blood-2011-02-297325 ID - Cavo2011 ER - TY - JOUR AU - Anderson, K. C. PY - 2012 DA - 2012// TI - The 39th David a. Karnofsky lecture: bench-to-bedside translation of targeted therapies in multiple myeloma JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.37.8919 DO - 10.1200/JCO.2011.37.8919 ID - Anderson2012 ER - TY - JOUR AU - Méndez, A. AU - Mendoza, L. PY - 2016 DA - 2016// TI - A network model to describe the terminal differentiation of B cells JO - PLoS Comput Biol VL - 12 UR - https://doi.org/10.1371/journal.pcbi.1004696 DO - 10.1371/journal.pcbi.1004696 ID - Méndez2016 ER - TY - JOUR AU - Boi, M. AU - Zucca, E. AU - Inghirami, G. AU - Bertoni, F. PY - 2015 DA - 2015// TI - PRDM1 /BLIMP1: a tumor suppressor gene in B and T cell lymphomas JO - Leuk Lymphoma VL - 56 UR - https://doi.org/10.3109/10428194.2014.953155 DO - 10.3109/10428194.2014.953155 ID - Boi2015 ER - TY - JOUR AU - Alinikula, J. AU - Nera, K. -. P. AU - Junttila, S. AU - Lassila, O. PY - 2011 DA - 2011// TI - Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation JO - Eur J Immunol VL - 41 UR - https://doi.org/10.1002/eji.201141553 DO - 10.1002/eji.201141553 ID - Alinikula2011 ER - TY - JOUR AU - Inagaki, Y. AU - Hayakawa, F. AU - Hirano, D. AU - Kojima, Y. AU - Morishita, T. AU - Yasuda, T. PY - 2016 DA - 2016// TI - PAX5 tyrosine phosphorylation by SYK co-operatively functions with its serine phosphorylation to cancel the PAX5-dependent repression of BLIMP1: a mechanism for antigen-triggered plasma cell differentiation JO - Biochem Biophys Res Commun VL - 475 UR - https://doi.org/10.1016/j.bbrc.2016.05.067 DO - 10.1016/j.bbrc.2016.05.067 ID - Inagaki2016 ER - TY - JOUR AU - Yao, G. PY - 2014 DA - 2014// TI - Modelling mammalian cellular quiescence JO - Interface Focus VL - 4 UR - https://doi.org/10.1098/rsfs.2013.0074 DO - 10.1098/rsfs.2013.0074 ID - Yao2014 ER - TY - JOUR AU - Wu, S. AU - Cetinkaya, C. AU - Munoz-Alonso, M. J. AU - von der Lehr, N. AU - Bahram, F. AU - Beuger, V. PY - 2003 DA - 2003// TI - Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206145 DO - 10.1038/sj.onc.1206145 ID - Wu2003 ER - TY - JOUR AU - Bretones, G. AU - Delgado, M. D. AU - León, J. PY - 2015 DA - 2015// TI - Myc and cell cycle control JO - Biochim Biophys Acta BBA - Gene Regul Mech VL - 1849 UR - https://doi.org/10.1016/j.bbagrm.2014.03.013 DO - 10.1016/j.bbagrm.2014.03.013 ID - Bretones2015 ER - TY - JOUR AU - Fecteau, J. -. F. AU - Corral, L. G. AU - Ghia, E. M. AU - Gaidarova, S. AU - Futalan, D. AU - Bharati, I. S. PY - 2014 DA - 2014// TI - Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53 JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-03-559591 DO - 10.1182/blood-2014-03-559591 ID - Fecteau2014 ER -